Avery Therapeutics, Inc. research brief

CIK 1708135 Copy CIK

Generated Nov. 11, 2026, 2:06 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: TUCSON AZ. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Sept. 21, 2026 · D · 0001708135-26-000003 · Source evidence

  Reported offering amount: 15400000 USD. Reported amount sold: 8468859 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Avery Therapeutics, Inc. research brief,” CIK 1708135, retrieved Nov. 11, 2026, 2:06 p.m.. Cite the specific accessions used. No amounts have been summed.